Product Information

NEOMYC-POLYM-DEXAMETH EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $1.7037 per ML under NDC 24208083060. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Sep 13, 1995. Its Orange Book therapeutic-equivalence code is AT.

NEOMYC-POLYM-DEXAMETH EYE DROP

Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone
$1.7037per ML

Strength

1; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL

NDC

24208083060

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA064135

FDA Approved

9/13/1995

TE Code

AT

On Market Since

9/13/1995

Pharmacological Classes

Aminoglycoside Antibacterial
Aminoglycosides
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Polymyxin-class Antibacterial
Polymyxins

Price Statistics

The NADAC for NEOMYC-POLYM-DEXAMETH EYE DROP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 46.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7037 per ML
All-time high$3.4623 (Apr 16, 2014)
All-time low$1.6081 (Jul 22, 2026)
52-week high$2.0996
52-week low$1.6081
Median price$2.6710
Average price$2.6334
Largest weekly change+23.5% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+5.9%

1M

+5.9%

3M

+5.7%

6M

+1.8%

1Y

-18.9%

3Y

-26.3%

5Y

-30.2%

All

-46.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of NEOMYC-POLYM-DEXAMETH EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for NEOMYC-POLYM-DEXAMETH EYE DROP, manufactured by Bausch & Lomb Incorporated, is $1.7037 per ML (NDC 24208083060), effective Aug 19, 2026.

How has the price of NEOMYC-POLYM-DEXAMETH EYE DROP changed over time?

Over the history we have for it, the NADAC for NEOMYC-POLYM-DEXAMETH EYE DROP has declined 46.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEOMYC-POLYM-DEXAMETH EYE DROP?

Since Nov 28, 2013, the NADAC for NEOMYC-POLYM-DEXAMETH EYE DROP has ranged from a low of $1.6081 (Jul 22, 2026) to a high of $3.4623 (Apr 16, 2014), with a median of $2.6710 per ML.

Are there cheaper alternatives to NEOMYC-POLYM-DEXAMETH EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of NEOMYC-POLYM-DEXAMETH EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NEOMYC-POLYM-DEXAMETH EYE DROP?

NEOMYC-POLYM-DEXAMETH EYE DROP (NDC 24208083060) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.